Literature DB >> 2523722

Size-dependent resistance of human tumour spheroids to photodynamic treatment.

C M West1.   

Abstract

Spheroids derived from the human colon adenocarcinoma cell line, WiDr, were exposed to 10 micrograms ml-1 Photofrin II and irradiated with light (700 nm, 50 mW cm-2). Compared with exponentially growing monolayer cultures, cells in spheroids of 100, 250 and 500 microns diameter were respectively 1.8, 2.5 and 22-fold less sensitive. The small resistance of plateau-phase cultures (1.3-fold) was insufficient to account for this marked spheroid size-dependent resistance. For monolayer cultures and for spheroids of 100 and 250 microns diameter, the results were the same whether irradiations were carried out pre- or post-trypsinisation. However, there was a difference for the largest spheroid size: when irradiations were carried out pre-trypsinisation, spheroids were more resistant than when irradiations were given post-trypsinisation. Drug extraction studies showed that there was no difference in the average drug uptake between cultures of exponentially growing or plateau-phase cells, and 100 microns diameter spheroids while 250 and 500 microns diameter spheroids took up proportionally 0.5 and 0.4 as much drug. Cell contact effects, drug heterogeneity between cells, hypoxia and problems in drug penetration are suggested as possible reasons for the resistance of large spheroids to photodynamic treatment.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2523722      PMCID: PMC2247149          DOI: 10.1038/bjc.1989.105

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  23 in total

1.  A comparison of serum kinetics and tissue distribution of photofrin II following intravenous and intraperitoneal injection in the mouse.

Authors:  M L Pantelides; J V Moore; N J Blacklock
Journal:  Photochem Photobiol       Date:  1989-01       Impact factor: 3.421

2.  Measurements on the depth of penetration of light (0.35--1.0 microgram) in tissue.

Authors:  J Eichler; J Knof; H Lenz
Journal:  Radiat Environ Biophys       Date:  1977-10-12       Impact factor: 1.925

3.  Effects of intercellular contact on repair of radiation damage.

Authors:  R E Durand; R M Sutherland
Journal:  Exp Cell Res       Date:  1972-03       Impact factor: 3.905

4.  Computer programmes for fitting Puck and probit survival curves.

Authors:  C W Gilbert
Journal:  Int J Radiat Biol Relat Stud Phys Chem Med       Date:  1969

5.  Resistance to adriamycin in multicellular spheroids.

Authors:  R M Sutherland; H A Eddy; B Bareham; K Reich; D Vanantwerp
Journal:  Int J Radiat Oncol Biol Phys       Date:  1979-08       Impact factor: 7.038

6.  Variable radiobiological responses of spheroids.

Authors:  R E Durand
Journal:  Radiat Res       Date:  1980-01       Impact factor: 2.841

7.  Photoinactivation of Chinese hamster cells by hematoporphyrin derivative and red light.

Authors:  C J Gomer; D M Smith
Journal:  Photochem Photobiol       Date:  1980-09       Impact factor: 3.421

8.  Plateau-phase cultures of mammalian cells: an in vitro model for human cancer.

Authors:  G M Hahn; J B Little
Journal:  Curr Top Radiat Res Q       Date:  1972-07

9.  Flow cytometry studies of intracellular adriamycin in multicell spheroids in vitro.

Authors:  R E Durand
Journal:  Cancer Res       Date:  1981-09       Impact factor: 12.701

10.  Photodynamic effects of haematoporphyrin derivative on synchronized and asynchronous cells of different origin.

Authors:  T Christensen; K Feren; J Moan; E Pettersen
Journal:  Br J Cancer       Date:  1981-11       Impact factor: 7.640

View more
  9 in total

Review 1.  Drug and radiation resistance in spheroids: cell contact and kinetics.

Authors:  P L Olive; R E Durand
Journal:  Cancer Metastasis Rev       Date:  1994-06       Impact factor: 9.264

2.  Differences in in vitro photodynamic sensitivity among head and neck cancers.

Authors:  V Boonkitticharoen; B Kulapaditharom; S Punnachaiya; P Kraiphibul
Journal:  Lasers Med Sci       Date:  1997-10       Impact factor: 3.161

3.  In vitro characterization of estrogen induced Syrian hamster renal tumors: comparison with an immortalized cell line derived from diethylstilbestrol-treated adult hamster kidney.

Authors:  A Gonzalez; T D Oberley; J L Schultz; J Ostrom; J J Li
Journal:  In Vitro Cell Dev Biol Anim       Date:  1993-07       Impact factor: 2.416

4.  Intraoperative photodynamic therapy as an adjunct to surgery for recurrent rectal cancer.

Authors:  S P Harlow; M Rodriguez-Bigas; T Mang; N J Petrelli
Journal:  Ann Surg Oncol       Date:  1995-05       Impact factor: 5.344

5.  Size-dependent Tumor Response to Photodynamic Therapy and Irinotecan Monotherapies Revealed by Longitudinal Ultrasound Monitoring in an Orthotopic Pancreatic Cancer Model.

Authors:  Michael Pigula; Huang-Chiao Huang; Srivalleesha Mallidi; Sriram Anbil; Joyce Liu; Zhiming Mai; Tayyaba Hasan
Journal:  Photochem Photobiol       Date:  2018-10-17       Impact factor: 3.421

6.  A comet assay of DNA damage and repair in K562 cells after photodynamic therapy using haematoporphyrin derivative, methylene blue and meso-tetrahydroxyphenylchlorin.

Authors:  F I McNair; B Marples; C M West; J V Moore
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

7.  Emergence of spatio-temporal variations in chemotherapeutic drug efficacy: in-vitro and in-Silico 3D tumour spheroid studies.

Authors:  M V Sheraton; G G Y Chiew; V Melnikov; E Y Tan; K Q Luo; N Verma; P M A Sloot
Journal:  BMC Cancer       Date:  2020-12-07       Impact factor: 4.430

8.  Photocytotoxic efficacy of sulphonated species of aluminium phthalocyanine against cell monolayers, multicellular spheroids and in vivo tumours.

Authors:  W S Chan; C M West; J V Moore; I R Hart
Journal:  Br J Cancer       Date:  1991-11       Impact factor: 7.640

9.  Preliminary evaluation of prostate-targeted radiotherapy using (131) I-MIP-1095 in combination with radiosensitising chemotherapeutic drugs.

Authors:  Mathias Tesson; Colin Rae; Colin Nixon; John W Babich; Robert J Mairs
Journal:  J Pharm Pharmacol       Date:  2016-05-03       Impact factor: 3.765

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.